Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Scherzer & Co. AG is a German-based company primarily focused on investment and asset management. Established to optimize the growth and value of its investment portfolio, Scherzer & Co. AG actively participates in diverse market opportunities. The company typically invests in undervalued small and mid-cap stocks, acquiring strategic stakes to support long-term development and value enhancement. Through a mix of minority holdings and significant influence stakes, Scherzer & Co. AG plays a substantial role in realigning and revitalizing businesses. Its investment strategy often leads to participation in various sectors, offering financial resources and strategic management support to drive performance and unlock potential. Key industries impacted by Scherzer & Co. AG's investments include technology, healthcare, and industrial sectors, among others. Headquartered in Germany, Scherzer & Co. AG not only enhances the operational efficacy of its portfolio companies but also contributes to their sustainability and competitive positioning in the market. In the financial market, Scherzer & Co. AG is recognized for its proactive investment approach, providing shareholders with value from both capital appreciation and control premiums, thereby positioning itself as a dynamic player in strategic equity investments.
79.19% operating margin is above average. ROIC at 5.25%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 59.9% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€5M
▼ -59.9% YoY
Net Income (TTM)
€5M
▲ +238.3% YoY
Op. Margin
79.19%
▲ +60.3pp YoY
ROIC
5.25%
▲ +3.3pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow
N/A
Net Debt
-€43M
Net Cash Position
Cash & Equiv.
€54M
3Y CAGR: -30.8%
Continue Research